Communes | Mosquito net | Number tested | Immediate mortality % (CI) | OR (CI) | p-value | Entry rate % | OR (CI) | p-value | Blood feeding rate % (CI) | Blood feeding inhibition (%) |
---|---|---|---|---|---|---|---|---|---|---|
(CI) | ||||||||||
Porto-Novo | Untreated Net | 100 | 1 [0.03–5.45] | 1 [NA] | 0.002 | 53 [42.76–63.06] | 1 [NA] | 4.55 | 55 [44.73–64.97] | 60 |
Interceptor® | 100 | 11 [5.62–18.83] | 12.12 [1.70–530.54] | 33 [23.92–43.12] | 0.43 [0.23–0.80] | 22 [14.33–31.39] | ||||
Untreated Net | 100 | 1 [0.03–5.45] | 1 [NA] | 0.00 | 53 [42.76–63.06] | 1 [NA] | 2.88 | 55 [44.73–64.97] | 89.09 | |
Interceptor® G2 | 100 | 69 [58.97–77.87] | 214.06 [34.19–8389.62] | 16 [9.43–24.68] | 0.17 [0.08–0.34] | 6 [2.23–12.6] | ||||
Bohicon | Untreated Net | 80 | 3.75 [0.78–10.57] | 1 [NA] | 4.56 | 56.25 [44.7–67.32] | 1 [NA] | 2.82 | 65 [53.52–75.33] | 51.92 |
Interceptor® | 80 | 37.5 [26.92–49.04] | 15.16 [4.36–81.70] | 38.75 [28.06–50.3] | 0.49 [0.24–0.96] | 31.25 [21.35–42.59] | ||||
Untreated Net | 80 | 3.75 [0.78–10.57] | 1 [NA] | 0.00 | 56.25 [44.7–67.32] | 1 [NA] | 1.16 | 65 [53.52–75.33] | 90.38 | |
Interceptor® G2 | 80 | 92.5 [84.39–97.2] | 286.04 [67.78–1867.59] | 16.25 [8.95–26.18] | 0.15 [0.06–0.33] | 6.25 [2.06–13.99] | ||||
Allada | Untreated Net | 80 | 2.5 [0.3–8.74] | 1 [NA] | 3.65 | 60 [48.44–70.8] | 1 [NA] | 1.70 | 55 [43.47–66.15] | 59.09 |
Interceptor® | 80 | 35 [24.67–46.48] | 20.66 [4.86–186.14] | 26.25 [17.04–37.29] | 0.23 [0.11–0.48] | 22.5 [13.91–33.21] | ||||
Untreated Net | 80 | 2.5 [0.3–8.74] | 1 [NA] | 0.00 | 60 [48.44–70.8] | 1 [NA] | 4.09 | 55 [43.47–66.15] | 100 | |
Interceptor® G2 | 80 | 72.5 [61.38–81.9] | 98.94 [23.17–917.26] | 7.5 [2.8–15.61] | 0.05 [0.01–0.14] | 0 [0–4.51] |